Oculus Innovative Sciences Company Profile (NASDAQ:OCLS)

Analyst Ratings

Consensus Ratings for Oculus Innovative Sciences (NASDAQ:OCLS) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.00 (34.64% downside)

Analysts' Ratings History for Oculus Innovative Sciences (NASDAQ:OCLS)
Show:
DateFirmActionRatingPrice TargetActions
6/17/2016Maxim GroupReiterated RatingBuy$3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/27/2014 forward)

Earnings

Earnings History for Oculus Innovative Sciences (NASDAQ:OCLS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/28/2016N/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
6/16/2016Q4($0.16)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/4/2016Q216($0.07)($0.19)$3.56 million$3.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2015Q116($0.10)($0.15)$3.96 million$3.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
6/11/2015Q215($0.25)($0.11)$3.12 million$3.98 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/12/2015Q115($0.18)($0.69)$3.10 million$3.22 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q1 15($0.17)($0.01)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
6/12/2014Q4 14($0.21)$0.99$3.42 million$2.91 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/19/2013Q2($0.15)($0.21)$4.03 million$4.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2013Q1 2014($0.26)($0.26)$3.68 million$3.37 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/13/2013Q3 2013($0.08)($0.05)$3.28 million$3.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2012Q312$0.03($0.05)$5.59 million$4.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Oculus Innovative Sciences (NASDAQ:OCLS)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Oculus Innovative Sciences (NASDAQ:OCLS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Oculus Innovative Sciences (NASDAQ:OCLS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
2/25/2016James J SchutzCEOBuy5,000$1.00$5,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/17/2014James J SchutzCEOBuy6,285$1.78$11,187.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/16/2013James SchutzCEOBuy5,100$2.35$11,985.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2012Hojabr AlimiCEOBuy5,500$0.64$3,520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/7/2012Hojabr AlimiCEOBuy5,300$0.65$3,445.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/9/2012James J SchutzCOOBuy13,000$0.80$10,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Oculus Innovative Sciences (NASDAQ:OCLS)
DateHeadline
07/26/16 08:19 AMOculus Innovative Sciences, Inc. :OCLS-US: Earnings Analysis: 2016 By the Numbers : July 26, 2016 -
07/22/16 08:33 AMOculus Innovative Sciences, Inc. (OCLS) Updated Price Targets - FTSE News
07/22/16 08:33 AMOculus Innovative Sciences Incorporated (NASDAQ:OCLS) Shorted Shares Increased By 25% - Consumer Eagle
07/20/16 08:30 AMOCULUS INNOVATIVE SCIENCES, INC.
07/19/16 11:56 AMETF’s with exposure to Oculus Innovative Sciences, Inc. : July 19, 2016 -
07/19/16 07:31 AMOculus Innovative Sciences Announces Fiscal First Quarter 2017 Financial Results and Conference Call - GlobeNewswire (press release)
07/19/16 03:05 AMOculus Innovative Sciences Announces Fiscal First Quarter 2017 Financial Results and Conference Call - [GlobeNewswire] - PETALUMA, Calif., July 19, 2016-- Oculus Innovative Sciences, Inc., today announced that the financial results for its fiscal first quarter 2017, ended June 30, 2016, will be released after the U.S. markets ...
07/18/16 11:00 AMNext Weeks Broker Price Targets For Oculus Innovative Sciences, Inc. (OCLS) - Fiscal Standard
07/13/16 08:32 AMSession Volatility Review for: Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) - Engelwood Daily
07/08/16 02:05 PMOculus Innovative Sciences, Inc. (OCLS) Current Analyst Ratings - Fiscal Standard
07/07/16 08:31 AMStocks Gaps Up – MAMS, CLUB, APWC, CARV, HMNY, LEDS, OCLS
07/07/16 08:31 AMOculus Innovative Sciences Announces Record Monthly and Quarterly Prescription Data
07/06/16 05:50 PMIncreased Volatility Watch for: Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) - Engelwood Daily
07/06/16 05:49 PMInsiders Increasing Positions in: Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) - Press Telegraph
07/06/16 10:13 AMOculus Innovative Sciences Announces Record Monthly and Quarterly Prescription Data - Yahoo Finance
07/05/16 05:22 PMHot Watch List: Microsoft Corporation (NASDAQ:MSFT), Teligent (NASDAQ:TLGT), Oculus Innovative Sciences ... - KC Register
07/05/16 05:22 PMBroker Outlook For The Week Ahead Oculus Innovative Sciences, Inc. (OCLS) - Fiscal Standard
07/01/16 08:22 AMRecently Issued Stock Ratings For Oculus Innovative Sciences, Inc. (OCLS) - Fiscal Standard
06/28/16 03:25 PMOCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, -
06/27/16 05:32 PMSECFilings.com : Examines Oculus Innovative Sciences' Financial Results and Turnaround Plan
06/27/16 09:47 AMMarket Movers: The Charles Schwab Corporation (NYSE:SCHW), Oculus Innovative Sciences, Inc. (NASDAQ:OCLS ... - KC Register
06/27/16 08:38 AMSECFilings.com Examines Oculus Innovative Sciences' Financial Results and Turnaround Plan - [Marketwired] - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, takes a look at Oculus Innovative Sciences' recently announced fourth quarter and fiscal ...
06/27/16 06:03 AMSplits Calendar: Oculus Innovative Sciences splits before market open today (1:5 ratio) -
06/25/16 12:04 PMOCULUS INNOVATIVE SCIENCES, INC. Financials -
06/25/16 09:19 AMRevenue Update on Oculus Innovative Sciences(NASDAQ:OCLS) - TheFounders Daily
06/23/16 06:08 PMOculus Innovative Sciences : Announces Reverse Split of Common Stock
06/23/16 12:47 PMETF’s with exposure to Oculus Innovative Sciences, Inc. : June 23, 2016 -
06/22/16 05:29 PMOculus Innovative Sciences Announces Reverse Split of Common Stock - GlobeNewswire (press release)
06/22/16 05:29 PMOculus Innovative Sciences (OCLS) Announces One-for-Five Reverse Stock Split - StreetInsider.com
06/22/16 11:34 AMOculus Innovative Sciences, Inc. :OCLS-US: Earnings Analysis: Q4, 2016 By the Numbers : June 22, 2016 -
06/22/16 10:20 AMOculus Innovative Sciences (OCLS) Announces One-for-Five Reverse Stock Split
06/22/16 04:20 AM5:20 am Oculus Innovative Sciences announces 1-for-5 reverse split of its common stock will be effective after the close of business on June 24 -
06/22/16 04:09 AMOculus Innovative Sciences Announces Reverse Split of Common Stock - [at noodls] - Focus on Continued Growth in U.S. Dermatology Market While Expanding Potential Institutional Investor Base PETALUMA, Calif., June 22, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: ...
06/21/16 03:27 PMOCULUS INNOVATIVE SCIENCES, INC. Files SEC form 10-K, Annual Report -
06/20/16 07:13 AMAnalyst Views For The Week Ahead: Oculus Innovative Sciences, Inc. (OCLS) - Fiscal Standard
06/17/16 05:26 PMOculus Innovative Sciences (OCLS): Building a Commercial Presence - Maxim Group
06/17/16 10:59 AMEdited Transcript of OCLS earnings conference call or presentation 16-Jun-16 8:30pm GMT -
06/17/16 08:23 AMOculus Innovative Sciences' (OCLS) CEO Jim Schutz on Q4 2016 Results - Earnings Call Transcript
06/17/16 08:23 AMOculus Innovative Sciences FY16 revenues up 9%
06/16/16 05:48 PMOCULUS INNOVATIVE SCIENCES, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
06/16/16 05:48 PMOculus Innovative Sciences Inc Earnings Call (Q4 2016)
06/16/16 03:09 PMOCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Stateme -
06/16/16 03:05 PMOculus Innovative Sciences Reports Financial Results for Fiscal Year 2016 and Fourth Quarter Ending March 31, 2016 - [GlobeNewswire] - Product Revenue for Fiscal Year 2016 Grew 31% Led by Growth in U.S. Conference Call Begins at 4:30pm EDT Today. PETALUMA, Calif., June 16, 2016-- Oculus Innovative Sciences, Inc., a specialty pharmaceutical ...
06/16/16 06:07 AMQ4 2016 Oculus Innovative Sciences Inc Earnings Release - After Market Close -
06/13/16 05:08 PMOculus Innovative Sciences, Inc. : annual earnings release
06/06/16 05:31 PMNew Broker Ratings For Oculus Innovative Sciences, Inc. (OCLS) - FTSE News
06/02/16 08:32 AMOculus Innovative Sciences Announces Financial Results for the Fiscal Year/Fourth Quarter 2016 and Conference Call - GlobeNewswire (press release) - Oculus Innovative Sciences Announces Financial Results for the Fiscal Year/Fourth Quarter 2016 and Conference CallGlobeNewswire (press release)PETALUMA, Calif., June 02, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), today announced that the financial results for its fiscal year and fourth quarter 2016, ended March 31, 2016, will be released after ...Insiders Are Gradually Buying Oculus Innovative Sciences, Inc. (NASDAQ:OCLS)HNNall 2 news articles »
06/02/16 03:25 AMOculus Innovative Sciences Announces Financial Results for the Fiscal Year/Fourth Quarter 2016 and Conference Call - [at noodls] - PETALUMA, Calif., June 02, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), today announced that the financial results for its fiscal year and fourth quarter 2016, ...
05/29/16 09:12 AMOculus Innovative Sciences, Inc. (NASDAQ:OCLS) Impact Score At 100 - Investor Newswire - Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) Impact Score At 100Investor NewswireAlpha One explored various online articles released on Oculus Innovative Sciences, Inc. (NASDAQ:OCLS), and it set a daily sentiment score of 0.171 on the company. The entity has an algorithm in place to know stock sentiment on the share after exploring ...and more »
05/29/16 09:12 AMOculus Innovative Sciences, Inc. (OCLS) Sees Large Decrease in Short Interest - Let Me Know About This - Oculus Innovative Sciences, Inc. (OCLS) Sees Large Decrease in Short InterestLet Me Know About ThisOculus Innovative Sciences logo Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) saw a significant decrease in short interest in the month of May. As of May 13th, there was short interest totalling 614,650 shares, a decrease of 18.5% from the April 29th ...

Social

About Oculus Innovative Sciences

Oculus Innovative Sciences logoOculus Innovative Sciences, Inc. is a specialty device and pharmaceutical company. The Company develops and markets solutions for the treatment of dermatological conditions and advanced tissue care in both humans and animals. The Company offers wound care products which are sold into the human and animal healthcare markets in the United States, Mexico and Europe. The Company also operates a microbiology contract testing laboratory division that provides consulting and laboratory services to medical companies that design and manufacture biomedical devices and drugs, as well as testing of products and the Company's products. The Company's key technology, Microcyn is based on electrically charged oxychlorine small molecules designed to target a range of pathogens that cause disease. The Company completed Phase II trials for Microcyn technology.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: OCLS
  • CUSIP:
Key Metrics:
  • Previous Close: $4.59
  • 50 Day Moving Average: $4.47
  • 200 Day Moving Average: $4.87
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $19.28M
  • Beta: 1.14
Additional Links:
Oculus Innovative Sciences (NASDAQ:OCLS) Chart for Wednesday, July, 27, 2016